These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2674 related articles for article (PubMed ID: 28875844)

  • 1. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors.
    Danhier F; Danhier P; De Saedeleer CJ; Fruytier AC; Schleich N; des Rieux A; Sonveaux P; Gallez B; Préat V
    Int J Pharm; 2015 Feb; 479(2):399-407. PubMed ID: 25578367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft matter assemblies as nanomedicine platforms for cancer chemotherapy: a journey from market products towards novel approaches.
    Jäger E; Giacomelli FC
    Curr Top Med Chem; 2015; 15(4):328-44. PubMed ID: 25633209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanodrugs used in cancer therapy.
    Kopeckova K; Eckschlager T; Sirc J; Hobzova R; Plch J; Hrabeta J; Michalek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):122-131. PubMed ID: 30967685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted nanomedicines for cancer theranostics.
    Arranja AG; Pathak V; Lammers T; Shi Y
    Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine therapeutic approaches to overcome cancer drug resistance.
    Markman JL; Rekechenetskiy A; Holler E; Ljubimova JY
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1866-79. PubMed ID: 24120656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
    Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicines for the treatment of hematological malignancies.
    Deshantri AK; Varela Moreira A; Ecker V; Mandhane SN; Schiffelers RM; Buchner M; Fens MHAM
    J Control Release; 2018 Oct; 287():194-215. PubMed ID: 30165140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer.
    Gurunathan S; Kang MH; Qasim M; Kim JH
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
    Jain V; Jain S; Mahajan SC
    Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Nanomedicines for Cancer Treatment.
    do Nascimento T; Todeschini AR; Santos-Oliveira R; de Souza de Bustamante Monteiro MS; de Souza VT; Ricci-Júnior E
    Curr Pharm Des; 2020; 26(29):3579-3600. PubMed ID: 32186271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
    Tanbour R; Martins AM; Pitt WG; Husseini GA
    Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in nanomedicine towards clinical application in oncology and immunology.
    Herreros E; Morales S; Cortés C; Cabaña M; Peñaloza JP; Jara L; Geraldo D; Otero C; Fernández-Ramires R
    Curr Pharm Biotechnol; 2014; 15(9):864-79. PubMed ID: 25213311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 134.